VigiBase™ Services
VigiBase™ is a unique collection of international drug safety data. The data is available in a wide range of services, from advanced neural network analysis to basic case report retrieval.
The VigiBase™ services will help you find useful information about the safety profile of your products as well as your competitors’. The services are used by pharmaceutical companies to get data with global coverage and compare the ADR profile of their product with other products. Other common usage areas are: signal detection, updating PSURs (Product Safety Update Reports) and to compare with the reports in your own company database.
Since 1978 the Uppsala Monitoring Centre (the UMC) has been the focal point of independent global pharmacovigilance. The Vigibase™ data resource is the largest and most comprehensive in the world, and is developed and maintained by the UMC on behalf of the World Health Organization.
The data held is collected from countries participating in WHO Programme for International Drug Monitoring. In April 2007, 82 countries participate in this programme. The member countries have access to the collected data and analyse it in order to investigate potential ADR signals and statistics and listings are also made on behalf of pharmaceutical companies and academia.
VigiBase™ comprises more than 3.8 million case reports, to which around 50,000 new reports are added quarterly. All of these cases are available to anyone with a health professional degree-level education (physician, dentist, nurse, pharmacist).